These events are designed to help you learn about the latest research and studies on AML.
Reducing Relapse Risk After Transplant Using Jakafi With Gabriela Hobbs, MD, Massachusetts General Hospital
Oct 05, 2022
Expanding the Use of Ivosidenib (Tibsovo) In Newly Approved Combination For IDH1-Mutated AML with Eytan Stein, MD, Memorial Sloan Kettering
Aug 24, 2022
ASH 2023: Revumenib Combined With Decitabine/Cedazuridine And Venetoclax For Relapsed Or Refractory AML